Clinical Trial

Transmission of Oncogenic HPV Infection Among Families

Study acronym: TREVINO
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of the Transmission of Oncogenic HPV Infection Among Families (TREVINO) study is to improve understanding of how high-risk human papillomavirus (HPV) infections are transmitted within families. The research focuses on transmission between sexual partners and between parents and children. It also examines how the various microbes may influence the persistence of HPV infections and the development of HPV-related cancers. The study will include up to 300 couples recruited from gynecology and ear, nose, and throat (ENT) clinics in Finland, as well as their children. Participants include individuals with persistent HPV infection, cervical precancer or cancer, or HPV-related head and neck cancer, along with their partners and potentially their offspring. Participants will provide self-collected samples from the oral and genital areas at multiple time points over up to five years. Questionnaires addressing medical, behavioural, and environmental factors will be completed. The study is conducted at Tampere University Hospital and Kuopio University Hospital in Finland. Results will inform HPV screening and prevention programs, improve understanding of family-level transmission, and identify potential microbial and genetic markers linked to cancer risk.
Trial Details
NCT Number NCT07036211
Lead Sponsor Tampere University Hospital
Collaborators: Kuopio University Hospital
Conditions Human Papilloma Virus (HPV), Cervical Carcinoma, Oropharyngeal Carcinoma, Transmission Vertical, Transmission, Human Papillomavirus Infection
Enrollment 700 participants
Start Date 2025-08
Primary Completion 2027-05 (estimated)
Study Completion 2031-12 (estimated)
Updated on ClinicalTrials.gov 2025-06-25